Michael C. Williams | Washington, D.C. | Hogan Lovells

Michael C. Williams
Williams Michael
  • Overview
  • Experience
  • Credentials
  • Insights and events

Michael Williams works with clients on a wide range of corporate and transactional matters, often in the life sciences, healthcare or general technology areas. Partnering with client legal and business leads, Michael focuses on understanding and helping clients achieve their critical business objectives.

Michael regularly handles matters for universities, non-profit hospitals and academic health systems as well as health care and life science companies. He also works with technology-oriented businesses outside the health care and life sciences sector. He frequently advises on complex transactions involving colleagues across specialty areas and geographic regions.

Michael counsels companies at each step, from their initial organization and financing through to maturity. He handles venture capital and strategic equity financings; buy- and sell-side M&A transactions; strategic collaborations; joint ventures; and complex contracts. He also advises on intellectual property protection, technology transfer and commercialization, governance, and other issues of critical importance to life science clients.

Over his 30-year career at Hogan Lovells, Michael has worked with a wide range of clients, from closely held and venture capital-backed private companies to academic health systems, nonprofit organizations, and public companies. He acts as outside general counsel for many of these clients.

Michael previously served as Co-Head of the firm's Global Citizenship Program and chair of the firm's Technology and Recruiting Committees. He serves on several charitable organization boards and is an adjunct faculty member at the University of Virginia School of Law. While in law school, Michael served as editor-in-chief of the Virginia Journal of International Law.

Representative experience

Represented a range of health systems on combinations, joint operating agreements and mergers.

Represented non-profit hospitals on acquisitions, dispositions and combinations of hospitals.

Advised a leading university on the structure of its technology transfer office in connection with the spin-off of its medical center.

Advised universities in connection with genomic research databases.

Represented a leading academic medical center on the establishment of a regional healthcare alliance joint venture.

Represented a leading university on negotiating a comprehensive management agreement for its affiliated hospital.

Acted as outside general counsel to a privately-held developer of transfection reagents, stem cell products, and other research tools before its sale to a strategic acquirer.

Represented the world's largest tissue bank, on joint development and distribution arrangements, with leading global medical device companies.

Represented two privately held molecular biology research products companies on their respective sales to strategic acquirers.

Represented a leading energy company on negotiating a joint venture to develop and commercialize a novel power generation technology.

Represented a leading online advertising technology company on venture capital financings, acquisitions, and other strategic transactions.

Represented a regional Blue Cross and Blue Shield plan on strategic venture investments and collaborations.

Represented a public biotechnology company on the sale of its biologics business, and licensing of a novel therapeutic vaccine candidate.

Credentials

Education
  • LL.M., University of Cambridge, 1985
  • J.D., University of Virginia School of Law, 1984
  • B.A., University of Virginia, with distinction, 1981
Bar admissions and qualifications
  • District of Columbia
Memberships
  • Board of Directors, Foundation for Management Education in Central America, 2008 - Present
  • Corporate Advisory Board, So Others Might Eat
  • Board of Directors, Global Rights, 2012 - 2015
  • Board of Directors, Public Welfare Foundation, 1996 - 2011